{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:14:07Z","timestamp":1778721247346,"version":"3.51.4"},"reference-count":96,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2013,3,25]],"date-time":"2013-03-25T00:00:00Z","timestamp":1364169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>High grade serous ovarian cancer (HGSC), the most lethal and frequent type of epithelial ovarian cancer (EOC), has poor long term prognosis due to a combination of factors: late detection, great metastatic potential and the capacity to develop resistance to available therapeutic drugs. Furthermore, there has been considerable controversy concerning the etiology of this malignancy. New studies, both clinical and molecular, strongly suggest that HGSC originates not from the surface of the ovary, but from the epithelial layer of the neighboring fallopian tube fimbriae. In this paper we summarize data supporting the central role of fallopian tube epithelium in the development of HGSC. Specifically, we address cellular pathways and regulatory mechanisms which are modulated in the process of transformation, but also genetic changes which accumulate during disease progression. Similarities between fallopian tube mucosa and the malignant tissue of HGSC warrant a closer analysis of homeostatic mechanisms in healthy epithelium in order to elucidate key steps in disease development. Finally, we highlight the importance of the cancer stem cell (CSC) identification and understanding of its niche regulation for improvement of therapeutic strategies.<\/jats:p>","DOI":"10.3390\/ijms14046571","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T04:34:12Z","timestamp":1364272452000},"page":"6571-6596","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["The Molecular Fingerprint of High Grade Serous Ovarian Cancer Reflects Its Fallopian Tube Origin"],"prefix":"10.3390","volume":"14","author":[{"given":"Mirjana","family":"Kessler","sequence":"first","affiliation":[{"name":"Max Planck Institute for Infection Biology, Department of Molecular Biology, Charit\u00e9platz 1, 11017 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Fotopoulou","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Charit\u00e9, Campus Virchow Clinic, University Hospital Augustenburger Platz 1, 13353 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Meyer","sequence":"additional","affiliation":[{"name":"Max Planck Institute for Infection Biology, Department of Molecular Biology, Charit\u00e9platz 1, 11017 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2013,3,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(10)62231-3","article-title":"Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995\u20132007 (the International Cancer Benchmarking Partnership): An analysis of population-based cancer registry data","volume":"377","author":"Coleman","year":"2011","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/AOG.0b013e318264f794","article-title":"Ten-year relative survival for epithelial ovarian cancer","volume":"120","author":"Baldwin","year":"2012","journal-title":"Obstet Gynecol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","article-title":"Rethinking ovarian cancer: Recommendations for improving outcomes","volume":"11","author":"Vaughan","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.humpath.2012.05.005","article-title":"PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma","volume":"44","author":"Abe","year":"2012","journal-title":"Hum. Pathol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1196333","article-title":"Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma","volume":"330","author":"Jones","year":"2010","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/path.1923","article-title":"High frequency of beta-catenin mutations in borderline endometrioid tumours of the ovary","volume":"208","author":"Oliva","year":"2006","journal-title":"J. Pathol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1158\/1078-0432.CCR-12-1103","article-title":"Pre-invasive ovarian mucinous tumors are characterized by CDKN2A and RAS pathway aberrations","volume":"18","author":"Hunter","year":"2012","journal-title":"Clin. Cancer Res"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ajpath.2011.01.009","article-title":"Somatic mutations of PPP2R1A in ovarian and uterine carcinomas","volume":"178","author":"Panuganti","year":"2011","journal-title":"Am. J. Pathol"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am. J. Hum. Genet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1158\/1078-0432.CCR-12-0199","article-title":"Prolonged postovulatory proinflammatory signaling in the fallopian tube epithelium may be mediated through a BRCA1\/DAB2 axis","volume":"18","author":"Tone","year":"2012","journal-title":"Clin. Cancer Res"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO;2-T","article-title":"K-ras mutations in mucinous ovarian tumors: A clinicopathologic and molecular study of 95 cases","volume":"79","author":"Cuatrecasas","year":"1997","journal-title":"Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-04-2509","article-title":"Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon","volume":"11","author":"Marquez","year":"2005","journal-title":"Clin. Cancer Res"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"12372","DOI":"10.1073\/pnas.1109363108","article-title":"Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer","volume":"108","author":"Cheung","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/en.2006-1054","article-title":"Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy","volume":"148","author":"Mittag","year":"2007","journal-title":"Endocrinology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol. Oncol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1097-0215(19970620)74:3<275::AID-IJC7>3.0.CO;2-W","article-title":"E-cadherin expression in human epithelial ovarian cancer and normal ovary","volume":"74","author":"Sundfeldt","year":"1997","journal-title":"Int. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00004347-198303000-00005","article-title":"Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125","volume":"2","author":"Kabawat","year":"1983","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/modpathol.2011.106","article-title":"Tubal origin of \u201covarian\u201d low-grade serous carcinoma","volume":"24","author":"Li","year":"2011","journal-title":"Mod. Pathol"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"(2011). Integrated genomic analyses of ovarian carcinoma. Nature, 474, 609\u2013615.","DOI":"10.1038\/nature10166"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: Experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Powell","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2012.06.015","article-title":"Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls","volume":"127","author":"Mingels","year":"2012","journal-title":"Gynecol. Oncol"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J. Clin. Oncol"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.bjc.6601692","article-title":"Clinical outcome of prophylactic oophorectomy in BRCA1\/BRCA2 mutation carriers and events during follow-up","volume":"90","author":"Olivier","year":"2004","journal-title":"Br. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation","volume":"296","author":"Finch","year":"2006","journal-title":"J. Am. Med. Assoc"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol. Oncol"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2013evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J. Pathol"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am. J. Surg. Pathol"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am. J. Surg. Pathol"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: Its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J. Clin. Oncol"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e10358","DOI":"10.1371\/journal.pone.0010358","article-title":"Genetic analysis of the early natural history of epithelial ovarian carcinoma","volume":"5","author":"Pothuri","year":"2010","journal-title":"PLoS One"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1470-2045(11)70333-3","article-title":"Assessment of symptomatic women for early diagnosis of ovarian cancer: Results from the prospective DOvE pilot project","volume":"13","author":"Gilbert","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J. Pathol"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1471-2407-10-237","article-title":"Expression signatures of TP53 mutations in serous ovarian cancers","volume":"10","author":"Bernardini","year":"2010","journal-title":"BMC Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1038\/sj.onc.1203013","article-title":"p53 regulation by post-translational modification and nuclear retention in response to diverse stresses","volume":"18","author":"Jimenez","year":"1999","journal-title":"Oncogene"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J. Pathol"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/path.2624","article-title":"The Li-Fraumeni syndrome (LFS): A model for the initiation of p53 signatures in the distal Fallopian tube","volume":"220","author":"Xian","year":"2010","journal-title":"J. Pathol"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/35056049","article-title":"Chromosomal stability and the DNA double-stranded break connection","volume":"2","author":"Hoeijmakers","year":"2001","journal-title":"Nat. Rev. Genet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/sj.onc.1207098","article-title":"Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability","volume":"23","author":"Richardson","year":"2004","journal-title":"Oncogene"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.embor.7400587","article-title":"p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene","volume":"7","author":"Kerr","year":"2006","journal-title":"EMBO Rep"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1101\/gad.11.10.1226","article-title":"Targeted mutations of breast cancer susceptibility gene homologs in mice: Lethal phenotypes of Brca1, Brca2, Brca1\/Brca2, Brca1\/p53, and Brca2\/p53 nullizygous embryos","volume":"11","author":"Ludwig","year":"1997","journal-title":"Genes Dev"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0092-8674(00)81302-1","article-title":"The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse","volume":"85","author":"Hakem","year":"1996","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jama.2012.20","article-title":"Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer","volume":"307","author":"Bolton","year":"2012","journal-title":"J. Am. Med. Assoc"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1158\/0008-5472.CAN-12-0324","article-title":"Clinicopathological features of homologous recombination-deficient epithelial ovarian cancers: Sensitivity to PARP inhibitors, platinum, and survival","volume":"72","author":"Mukhopadhyay","year":"2012","journal-title":"Cancer Res"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1200\/JCO.2010.34.2980","article-title":"Secondary somatic mutations restoring BRCA1\/2 predict chemotherapy resistance in hereditary ovarian carcinomas","volume":"29","author":"Norquist","year":"2011","journal-title":"J. Clin. Oncol"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/path.2927","article-title":"Identification of abrogated pathways in fallopian tube epithelium from BRCA1 mutation carriers","volume":"225","author":"George","year":"2011","journal-title":"J. Pathol"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/bjc.2011.371","article-title":"Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition","volume":"105","author":"Tsilidis","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/ERC-11-0107","article-title":"The impact of ovulation on fallopian tube epithelial cells: Evaluating three hypotheses connecting ovulation and serous ovarian cancer","volume":"18","author":"King","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S1470-2045(11)70165-6","article-title":"Risk of ovarian cancer in women with pelvic inflammatory disease: A population-based study","volume":"12","author":"Lin","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1086\/652395","article-title":"Risk of sequelae after Chlamydia trachomatis genital infection in women","volume":"201","author":"Haggerty","year":"2010","journal-title":"J. Infect. Dis"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF00141802","article-title":"Serum IgG and IgA antibodies specific for Chlamydia trachomatis in salpingitis patients as determined by the immunoperoxidase assay","volume":"1","author":"Piura","year":"1985","journal-title":"Eur. J. Epidemiol"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1099\/00221287-136-6-1109","article-title":"Chlamydia trachomatis infection of human fallopian tube organ cultures","volume":"136","author":"Cooper","year":"1990","journal-title":"J. Gen. Microbiol"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1111\/j.1462-5822.2007.00996.x","article-title":"Interleukin-1 is the initiator of Fallopian tube destruction during Chlamydia trachomatis infection","volume":"9","author":"Hvid","year":"2007","journal-title":"Cell Microbiol"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ajpath.2010.11.019","article-title":"Chlamydia trachomatis infection increases fallopian tube PROKR2 via TLR2 and NFkappaB activation resulting in a microenvironment predisposed to ectopic pregnancy","volume":"178","author":"Shaw","year":"2011","journal-title":"Am. J. Pathol"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2249.2004.02564.x","article-title":"Cytokine expression pattern in the genital tract of Chlamydia trachomatis positive infertile women-implication for T-cell responses","volume":"137","author":"Reddy","year":"2004","journal-title":"Clin. Exp. Immunol"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ajpath.2011.09.015","article-title":"Chlamydia trachomatis disturbs epithelial tissue homeostasis in fallopian tubes via paracrine Wnt signaling","volume":"180","author":"Kessler","year":"2012","journal-title":"Am. J. Pathol"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1128\/IAI.01404-09","article-title":"Role of high-mobility group box 1 protein and poly(ADP-ribose) polymerase 1 degradation in Chlamydia trachomatis-induced cytopathicity","volume":"78","author":"Yu","year":"2010","journal-title":"Infect. Immun"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1462-5822.2009.01307.x","article-title":"Centrosome abnormalities during a Chlamydia trachomatis infection are caused by dysregulation of the normal duplication pathway","volume":"11","author":"Johnson","year":"2009","journal-title":"Cell Microbiol"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1462-5822.2011.01642.x","article-title":"HIF-1alpha is involved in mediating apoptosis resistance to Chlamydia trachomatis-infected cells","volume":"13","author":"Sharma","year":"2011","journal-title":"Cell Microbiol"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1086\/368380","article-title":"Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer","volume":"187","author":"Ness","year":"2003","journal-title":"J. Infect. Dis"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"219672","DOI":"10.1155\/2008\/219672","article-title":"Chlamydia trachomatis serology in women with and without ovarian cancer","volume":"2008","author":"Ness","year":"2008","journal-title":"Infect. Dis. Obstet. Gynecol"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"824627","DOI":"10.1155\/2011\/824627","article-title":"Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors","volume":"2011","author":"Idahl","year":"2011","journal-title":"Infect. Dis. Obstet. Gynecol"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/j.ijid.2010.12.005","article-title":"Identification of novel markers for uncomplicated lower genital tract infections and upper genital tract pathology due to Chlamydia trachomatis","volume":"15","author":"Collet","year":"2011","journal-title":"Int. J. Infect. Dis"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1593\/neo.11138","article-title":"Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma","volume":"13","author":"Jazaeri","year":"2011","journal-title":"Neoplasia"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1073\/pnas.1017300108","article-title":"Modeling high-grade serous ovarian carcinogenesis from the fallopian tube","volume":"108","author":"Karst","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.1117135109","article-title":"High-grade serous ovarian cancer arises from fallopian tube in a mouse model","volume":"109","author":"Kim","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1593\/neo.08784","article-title":"Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations","volume":"10","author":"Sangha","year":"2008","journal-title":"Neoplasia"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.23448","article-title":"Consortium analysis of 7 candidate SNPs for ovarian cancer","volume":"123","author":"Ramus","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0090-8258(90)90069-W","article-title":"c-myc amplification in ovarian cancer","volume":"38","author":"Baker","year":"1990","journal-title":"Gynecol. Oncol"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/cncr.24987","article-title":"Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer","volume":"116","author":"Nakayama","year":"2010","journal-title":"Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0002-9440(10)64681-0","article-title":"Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas","volume":"158","author":"Kurose","year":"2001","journal-title":"Am. J. Pathol"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccr.2011.08.016","article-title":"FoxM1 promotes beta-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis","volume":"20","author":"Zhang","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_72","first-page":"4773","article-title":"FOXM1 is a downstream target of Gli1 in basal cell carcinomas","volume":"62","author":"Teh","year":"2002","journal-title":"Cancer Res"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e23790","DOI":"10.1371\/journal.pone.0023790","article-title":"Aberrant activation of ERK\/FOXM1 signaling cascade triggers the cell migration\/invasion in ovarian cancer cells","volume":"6","author":"Lok","year":"2011","journal-title":"PLoS One"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1172\/JCI27527","article-title":"A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment","volume":"117","author":"Gusarova","year":"2007","journal-title":"J. Clin. Invest"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Cheng, J.C., Chang, H.M., and Leung, P.C. (2012). Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells. Oncogene.","DOI":"10.1038\/onc.2012.127"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2407-12-91","article-title":"EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer","volume":"12","author":"Haslehurst","year":"2012","journal-title":"BMC Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/1078-0432.CCR-10-2325","article-title":"Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells","volume":"17","author":"Rosano","year":"2011","journal-title":"Clin. Cancer Res"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1097\/IGJ.0b013e3182738307","article-title":"Prognostic impact of the cancer stem cell-related marker NANOG in ovarian serous carcinoma","volume":"22","author":"Lee","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Siu, M.K., Wong, E.S., Kong, D.S., Chan, H.Y., Jiang, L., Wong, O.G., Lam, E.W., Chan, K.K., Ngan, H.Y., and Le, X.F. (2012). Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers. Oncogene.","DOI":"10.1038\/onc.2012.363"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"34970","DOI":"10.1074\/jbc.M112.374611","article-title":"MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53\/Nanog","volume":"287","author":"Xu","year":"2012","journal-title":"J. Biol. Chem"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/ng.239","article-title":"Lgr5 marks cycling, yet long-lived, hair follicle stem cells","volume":"40","author":"Jaks","year":"2008","journal-title":"Nat. Genet"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nature06196","article-title":"Identification of stem cells in small intestine and colon by marker gene Lgr5","volume":"449","author":"Barker","year":"2007","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2009.11.013","article-title":"Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro","volume":"6","author":"Barker","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/stem.1207","article-title":"Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: A site for injury and serous cancer initiation","volume":"30","author":"Paik","year":"2012","journal-title":"Stem Cells"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2353\/ajpath.2010.100316","article-title":"Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin","volume":"177","author":"Park","year":"2010","journal-title":"Am. J. Pathol"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"E2939","DOI":"10.1073\/pnas.1206400109","article-title":"Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy","volume":"109","author":"McAuliffe","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","article-title":"Identification and characterization of ovarian cancer-initiating cells from primary human tumors","volume":"68","author":"Zhang","year":"2008","journal-title":"Cancer Res"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/cc.8.1.7533","article-title":"Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance","volume":"8","author":"Alvero","year":"2009","journal-title":"Cell Cycle"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1158\/0008-5472.CAN-10-3175","article-title":"Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival","volume":"71","author":"Silva","year":"2011","journal-title":"Cancer Res"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1073\/pnas.1120733109","article-title":"Human ovarian cancer stem\/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance","volume":"109","author":"Meirelles","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ijc.25967","article-title":"Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells","volume":"130","author":"Kryczek","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/stem.1194","article-title":"Autocrine CCL5 signaling promotes invasion and migration of CD133+ ovarian cancer stem-like cells via NF-kappaB-mediated MMP-9 upregulation","volume":"30","author":"Long","year":"2012","journal-title":"Stem Cells"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4161\/cbt.22959","article-title":"Endothelin receptor-A is required for the recruitment of anti-tumor T cells and modulates chemotherapy induction of cancer stem cells","volume":"14","author":"Coffman","year":"2012","journal-title":"Cancer Biol. Ther"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","article-title":"A CXCL1 paracrine network links cancer chemoresistance and metastasis","volume":"150","author":"Acharyya","year":"2012","journal-title":"Cell"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/4\/6571\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:45:44Z","timestamp":1760219144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/4\/6571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,25]]},"references-count":96,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4]]}},"alternative-id":["ijms14046571"],"URL":"https:\/\/doi.org\/10.3390\/ijms14046571","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,25]]}}}